New drug tested for rare energy disorder
Disease control
Completed
This study tested an experimental drug called OMT-28 for people with primary mitochondrial disease, a rare condition where the body's energy-producing cells don't work properly. Researchers gave 28 patients the daily medication for 6 months to check if it was safe, reduced certai…
Phase: PHASE2 • Sponsor: Omeicos Therapeutics GmbH • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC